Chadwick Jeremy G (CIK 1388406) reported 41 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-27). Recent activity: Sell KYMR (3,730 shares), Sell KYMR (324 shares), Sell KYMR (3,800 shares), Sell KYMR (4,500 shares), Sell KYMR (551 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-27 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 3,730 | $292,283 |
| 2026-05-27 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 324 | $25,651 |
| 2026-05-27 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 3,800 | $301,682 |
| 2026-05-27 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 4,500 | $360,090 |
| 2026-05-27 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 551 | $44,471 |
| 2026-05-27 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 3,679 | $299,838 |
| 2026-05-27 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 600 | $49,248 |
| 2026-04-24 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 100 | $3,017 |
| 2026-04-24 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 200 | $8,700 |
| 2026-04-24 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 300 | $27,000 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 5,251 | $472,590 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 785 | $34,148 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 4,466 | $134,739 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 1,300 | $56,550 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 1,300 | $117,000 |
| 2026-04-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 7,600 | $225,264 |
| 2026-04-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 7,600 | $648,888 |
| 2026-04-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 14,640 | $433,930 |
| 2026-04-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 13,540 | $1.2M |
| 2026-04-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 1,100 | $94,655 |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Buy | 84,400 | $2.5M |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 22,756 | $1.7M |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 52,975 | $4.1M |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 8,214 | $643,978 |
| 2026-03-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Operating Officer | Sell | 6,105 | $487,606 |
来源：SEC Form 4 申报文件 · 截至 2026-05-27